Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(PharmaTimes [UK]) June 22, 2018 - US regulators have accepted Bristol-Myers Squibb’s application to market Opdivo plus Yervoy for the treatment of first-line advanced non-small cell lung cancer (NSCLC) in certain patients.
Read Article
(STAT) June 22, 2018 - Immunotherapy is effective against a variety of cancers, with sometimes spectacular results. But I worry about how effective it is in people over age 65, who make up half of cancer patients.
Read Article
Latest Articles
June 22, 2018
June 22, 2018
June 21, 2018
June 21, 2018
June 21, 2018
June 21, 2018
June 20, 2018
June 19, 2018
View More
News Commentary
Editor Image
27 Jul, 2017 | by H. Jack West, MD
This is a very important negative result, as far too many thoracic oncology...
View Comment
Editor Image
27 Jul, 2017 | by H. Jack West, MD
This is an important trial and a potential totally practice-changing result,...
View Comment
View More
OBR Green
View More
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.